Kamada (XTAE:KMDA) Short Percentage of Float

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTAE:KMDA Kamada Ltd XTAE:KMDA
84 GF Score
Price ₪21.80
GF Value ₪25.14
Valuation Modestly Undervalued
View Full Analysis

What is Kamada Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

XTAE:KMDA vs ZTS, UTHR, VTRS: Short Percentage of Float Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Kamada's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kamada Short Percentage of Float vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kamada's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Kamada's Short Percentage of Float falls into.


XTAE:KMDA
84GF Score
Kamada Ltd XTAE:KMDA
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Kamada (XTAE:KMDA) Overvalued in 2026?

Based on GuruFocus' analysis, Kamada stock appears to be undervalued. The current stock price of ₪21.80 is trading 13.3% below its estimated GF Value™ of ₪25.14. GuruFocus considers Kamada to be Modestly Undervalued.

Key valuation signals for XTAE:KMDA:

  • Short Percentage of Float:
  • GF Value™: ₪25.14 vs. price of ₪21.80 (13.3% below fair value)
  • GF Score™: 84/100

No single metric tells the full story. See the XTAE:KMDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kamada Business Description

Other Exchanges KMDA:USA
Address 2 Holzman Street, P.O. Box 4081, Science Park, Rehovot, ISR, 7670402
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
84GF Score

Get the complete analysis for XTAE:KMDA

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪21.80
Price
₪25.14
GF Value